As a leading domestic supplier of quantitative PCR systems, in 2022, Rocgene's "Little Amy" fleet was successively deployed to third-party laboratories, CDCs, hospitals, and mobile cabin hospitals. With high-quality and stable product performance, it provided reliable support for frontline anti-epidemic staff.

The Quality Management Team at Rocgene Xuzhou Intelligent Manufacturing Center has been strictly supervising the production and testing process to ensure the quality of Rocgene products. The excellent and consistent performance of "Little Amy" is attributed to strict production requirements and rigorous pre-delivery testing.

Although not on the frontline of epidemic prevention, Rocgene Xuzhou Intelligent Manufacturing Center has built two sets of standard PCR laboratories to ensure stable performance of "Little Amy". All reagents, consumables and operations comply with the requirements for biosafety level 2 laboratories in terms of protective equipment, personal protection and operating protocols.

Sample Preparation Area

Nucleic Acid Amplification Area (Instrument Testing Area)

Before delivery, every "Little Amy" instrument undergoes complete performance verification in the PCR laboratory. Only after passing inspection by the Quality Management Team can it be released.

Reliable product quality is the foundation for a company to gain customer recognition, and ensuring the quality of each instrument is our bottom line.

As a key material for COVID-19 prevention and control, Rocgene "Little Amy" has been in short supply many times. The Xuzhou Intelligent Manufacturing Center has worked overnight to meet urgent orders. Despite heavy production pressure, the Quality Management Team never reduced testing procedures, firmly upholding the quality standard of Rocgene products.